BCR-ABL Cepheid Developing New Target for BCR-ABL Test for Leukemia Patients Premium The firm's new application of its BCR-ABL test will be able to detect p190 transcripts and is currently for research use only. At AACR, Stanford Team Shares Single-Cell Fusion Detection Tool For Mapping Tumor Cells The SICILIAN algorithm, which uses statistical modeling to score candidate fusions in single-cell RNA sequencing data, is being used to map splice sites in individual tumor cells. Cepheid Xpert BCR-ABL Ultra Leukemia Monitoring Test Gets FDA Clearance The in vitro diagnostic test can deliver molecular results from whole blood samples in less than three hours, the company said. Health Canada Approves Two BCR-ABL Tests The tests from Asuragen and MolecularMD are designed for use in chronic myeloid leukemia patients, including those receiving tyrosine kinase inhibitor therapy. MolecularMD, Genoptix Ink Marketing Agreement for CDx to Novartis CML Drug The companion diagnostic test identifies patients taking the Novartis drug Tasigna who are candidates for treatment-free remission monitoring. Jan 19, 2018 Italian Team Developing Nanopore Sequencing, Droplet Digital PCR Test to Monitor Residual Disease Premium Jan 17, 2018 Asuragen Gets CE Mark for QuantideX BCR-ABL Kits on Roche Platform Dec 27, 2017 MolecularMD Gets FDA Authorization for Companion Dx to Novartis CML Drug Dec 5, 2017 Bio-Rad Gets First CE Mark on Clinical ddPCR Test Jul 25, 2016 Asuragen BCR-ABL Kit Granted FDA Premarket Clearance Feb 5, 2016 Digital PCR Approach Can Detect CML Present in Patients at Low Levels, Study Says Jun 11, 2015 Asuragen BCR-ABL Assay Receives CE Mark Jul 17, 2014 Australian Studies Suggest BCR-ABL1 Compound Mutations in CML Patients May be PCR Artifacts Premium Mar 14, 2013 Dx Focus: Quidel RSV/hMPV Test Gets 510(k); Labceutics, Asuragen Partner on BCR-ABL1 Standardization Premium Jan 17, 2013 Australia's Monoquant Developing PCR-Based DNA Assay to Monitor CML Patients Premium Sep 5, 2012 FDA Approves Pfizer's Chronic Philadelphia Chromosome-Positive CML Drug Bosulif Premium Jul 25, 2012 MDx/CDx Focus: Cepheid Updates BCR-ABL Test; Medicare Covers Transgenomic Plavix Dx; Lungevity Awards Premium Feb 1, 2012 MDx/CDx Focus: FDA Accepts Pfizer's Bosutinib NDA; Kalydeco Approval; AssureRx Credit Line; and more Premium Dec 7, 2011 Novartis MDx Could See Near-Term Promise in 'Complementary' Diagnostics Over Companion Tests Premium Jun 8, 2011 Medco Taps MolecularMD to Provide BCR-ABL Testing for TKI Inhibitors in CML Patients Premium Jun 2, 2011 Dx Focus Jun 2, 2011: Clinical and Regulatory PCR and Nucleic Acid Testing News Premium Mar 3, 2011 UK Researchers Developing Duplex qPCR Assay to Monitor BCR-ABL1-Linked Blood Cancers Premium Dec 15, 2010 New Releases: Dec 15, 2010 Premium Dec 9, 2010 Asuragen to Develop BCR-ABL1 RT-qPCR Testing Calibrators, Software for Novartis Premium Dec 8, 2010 Asuragen Signs Deal with Novartis to Develop Standardization Tools for BCR-ABL Monitoring Premium Load More Breaking News Bio-Rad Laboratories Q2 Revenues Climb 33 Percent, Beat Estimates Veracyte Q2 Revenues More Than Double on Test Volume Spike Increased Testing Revenues Boost Opko Health Q2 Revenues 47 Percent Qiagen Q2 Revenues Grow 28 Percent CareDx Q2 Revenues Up 77 Percent Secondary Genetic Findings Often Requested if Given Second Chance, Study Finds The Scan Booster Push New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high. With Help from Mr. Fluffington, PurrhD Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic. Man Charged With Threatening to Harm Fauci, Collins The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials. Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.